Du forlater nå GSKs nettsider

Denne lenken tar deg til en nettside som ikke tilhører GSK. GSK er ikke ansvarlig for, går ikke god for og aksepterer intet ansvar for informasjon eller meninger på nettsteder til tredjeparter

Fortsett

Tilbake

HIV overview

GSK and ViiV Healthcare are committed to providing innovative medicines for people living with HIV. Here you can access the latest information on our HIV portfolio.

These medicinal products are subject to additional monitoring.

Reference:

  1. Llibre JM, Walmsley S, Gatell JM. Backbones versus core agents in initial ART regimens: one game, two players. J Antimicrob. Chemother. (2016); 71 (4): 856-861.

TRIUMEQ and TIVICAY trademarks are owned by or licensed to the ViiV Healthcare group of companies.